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514 C.-H. Cherng et al.Methods: Neuropathic pain was induced by tight ligation of the left L5 spinal nerve of the rats.
An intrathecal catheter was implanted for drug administration. Nociception was assessed by
using the plantar test with the Hargreaves radiant heat apparatus, and the von Frey test with
the dynamic plantar anesthesiometer. Spinal cords were removed for histone acetyl-H3 and
HDAC1 western blot analysis at the end of the nociceptive assessment.
Results: The results showed that hyperalgesia and allodynia were observed in the spinal nerve
ligated (SNL) left hindlimb; it was companied by histone-H3 deacetylation and HDAC1 overex-
pression on the ipsilateral side of the spinal cord dorsal horn. Intrathecal injection of baicalin
(10 mg) significantly attenuated the allodynia and hyperalgesia, and enhanced the antinocicep-
tive effect of morphine (15 mg). Moreover, baicalin reversed the histone-H3 acetylation and
suppressed HDAC1 expression on the ipsilateral side of the spinal cord dorsal horn of SNL rats.
Conclusion: The present findings suggest that baicalin can ameliorate neuropathic pain by sup-
pressing HDAC1 expression and preventing histone-H3 acetylation in the spinal cord dorsal horn
of SNL rats.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Neuropathic pain, as defined by the International Asso-
ciation for the Study of Pain (IASP), is the result of a
primary lesion or dysfunction of the nervous system;
thermal hyperalgesia and tactile allodynia are well-
documented symptoms of neuropathic pain in both clin-
ical settings and animal models. The underlying cellular
and molecular mechanisms of neuropathic pain remain
controversial.1 Recent evidence suggests that expression
of pain-associated genes in sensory neurons, immune
cells, and glial cells are highly involved in the generation
and maintenance of neuropathic pain.2 Epigenetic
mechanisms may induce heritable changes in gene
expression, however, without changing the DNA
sequence, which regulate the transcription and expres-
sion of pro- or antinociceptive genes.3 Evidence indicates
that epigenetic modifications influence the inflammatory
process.4,5 Moreover, histone deacetylases (HDACs)
have also demonstrated suppression of cytokine expres-
sion, including interleukin-1b (IL-1b) and tumor necrosis
factor-a (TNF-a).6 Binding of these proinflammatory
cytokines to their receptors can modulate epigenetic
processing. Furthermore, histone methylation was
demonstrated recruiting nuclear factor-kB (NF-kB) to
proinflammatory genes,7 and Marchand et al (2005) also
demonstrated that peripheral chronic inflammatory pains
are controlled by similar mechanisms.8
Although neuropathic pain responds to opioids, the re-
sults are unsatisfactory and adjuvant drugs are often
needed. Scutellaria baicalensis Georgi (Huang Qui) is an
important medicinal herbdit is widely used for the treat-
ment of various inflammatory diseases, hepatitis, tumors,
and diarrhea in Asia.9 Baicalin (7-glucuronic acid,5,6-
dihydroxyflavone), a flavonoid compound isolated from
Huang Qin, possesses antioxidant properties10 and has an
analgesic effect on carrageenan-induced thermal hyper-
algesia11; this suggests that Baicalin may be a potential
adjuvant, in combination with opioids, for treating neuro-
pathic pain. In our present study, spinal nerve ligation (SNL)
was used on rats to induce a central neuropathic pain
model; this method has been widely used to assess thepotential of drugs in clinical neuropathic pain treatment.
The primary objective of this study was to examine the
antinociceptive effect of baicalin, in particular when using
together with morphine, and the change in epigenetics in
the SNL rat spinal cord dorsal horn.
Materials and methods
The study protocol was reviewed and approved by the An-
imal Care and Use Committee of the National Defense
Medical Center. Male Wistar rats (300e350 g) were housed
individually with soft bedding in a 12-hour night/day cycle
with free access to food and water at all times. All efforts
were made to minimize the number of animals used and
their suffering.
Animal preparation
Under 2e2.5% isoflurane anesthesia, rats were implanted
with an intrathecal catheter. The intrathecal catheter was
constructed as described previously.12e15 The rat was placed
prone in a stereotaxic frame, the cisternal membrane was
exposed, and a polyethylene catheter (PE-10 tubing, 8.0 cm)
was inserted through a small puncture in the membrane and
threaded caudally to reach the lumbar enlargement of the
spinal cord. Neuropathic painwas induced by SNL of rats as in
the previous study.16 All rats then underwent either SNL or
sham operation. In the SNL rats, a small incision to the skin
overlying L5-S1 was made, followed by retraction of the
paravertebral musculature from the vertebral transverse
processes, and the left L6 transverse process was partially
removed to expose the L5 and L6 spinal nerves. The L5 spinal
nerve was identified, lifted slightly, and transected. The L5
spinal nerve was then isolated and tightly ligated with 6-0
silk. The wound was closed in two layers with a 3-0 polyester
suture (facial plane) and surgical skin staples. With regard to
the sham-operated animals, the left L5 nerve was exposed
without ligation. Rats with neurological deficits were
excluded. Seven days after SNL, rats were randomly given
saline alone (5 mL), or baicalin (10 mg in 5 mL of saline; Wako
Pure Chemical Industries, Osaka, Japan) was given 30
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via intrathecal catheter and followed by 8 mL of saline
to flush the catheter. After drug administration, the rats
were randomly assigned to thermal or tactile nociceptive
tests.
Nociceptive tests
Tactile allodynia
Tactile allodynia of the plantar surface was assessed using
an automated von Frey Dynamic Plantar Anesthesiometer
(Ugo Basile, Comerio, Italy), which does not produce tissue
damage.17 Each rat was placed in an individual plastic cage
(25 cm long  10 cm wide  14 cm high) with a wire mesh
floor and acclimatized to the cage for 15 minutes before
each test session. The paw withdrawal latency was elicited
by applying an increasing force using a blunt-end metal
filament (0.5 mm in diameter) focused on the middle of the
plantar surface of the hindpaw. The force was initially
below the detection threshold, and then increased from 1 g
to 50 g in 1-g steps over 20 seconds; the endpoint was
holding the filament at 50 g for a further 10 seconds. The
rate of force increase was 2.5 g/second. The latency was
recorded as the force eliciting the hindpaw removal reflex,
which was recorded as the mean of three measurements at
1-minute intervals.
Thermal hyperalgesia
Heat sensitivity was examined using a Hargreaves radiant
heat apparatus (7371; Ugo Basile; infrared setting, 80).
The rat was placed in a plastic cage (23 cm long  18 cm
wide  14 cm high) and allowed to acclimatize to the cage
for 30 minutes before the behavioral test. The cage was
then placed on a glass plate above the plantar test appa-
ratus and a movable noxious heat source placed directly
under the plantar surface of the hindpaw. When activated,
the apparatus applied a continuous infrared heat stimulus
to the plantar surface and a distinctive paw withdrawal
reflex was elicited, which stopped an automated timer
(based on infrared reflection). The hindpaws were tested
alternately, with a 5-minute interval between consecutive
tests. Three measurements of latency were averaged for
each hindpaw in each test session. The baseline threshold
was between 8 seconds and 10 seconds in normal rats and
a 22-second cutoff time was used to prevent tissue
damage.
Spinal cord preparation and Western blotting
analysis
After the behavior experiment, all rats were rapidly
decapitated and the dorsal portion of the lumbar spinal
cord enlargement removed and stored at e80C until used
for Western blotting. The dorsal part of the ipsilateral
spinal cord was fractionated into cytosolic, membrane, and
nuclear fractions using a cytoplasmic, nuclear, and mem-
brane (CNM) compartment protein extraction kit as rec-
ommended by the manufacturer (Biochain Institute Inc.,
Hayward, CA, USA). Sample loading was checked using
mouse anti-rat histone H3 (Upstate Inc., Lake Placid, NY,
USA) antibodies. Samples were separated on a 10% sodiumdodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) gel, and electrotransferred to a 0.2 mm poly-
vinylidene fluoride (PVDF) membrane (Bio-Rad Labora-
tories, Inc., Hercules, CA, USA). The membrane was
blocked for 1 hour at room temperature with 5% albumin
from bovine serum (Sigma, Missouri, USA) in Tris-buffered
saline containing 0.1% Tween 20 and incubated overnight
at 4C with rabbit polyclonal antibodies against rat
acetyl-histone 3 (Upstate Inc., Lake Placid, NY, USA) and
histone deacetylase 1 (HDAC1; Cell Signaling Technology
Inc., USA), and then for 1 hour at room temperature with
horseradish peroxidase-conjugated goat anti-rabbit IgG
antibody as appropriate (Chemicon, Temecula, CA, USA).
After the reaction of the blots with Enhanced Chem-
iluminescence (ECL) solution (Amersham, Arlington
Heights, IL, USA), bound antibody was visualized using a
chemiluminescence imaging system (Syngene, Cambridge,
UK). Finally, the blots were incubated for 18 minutes at
56C in stripping buffer (62.6 mM Tris-HCl, pH 6.7, 2% SDS,
100 mM mercaptoethanol) and reprobed with a monoclonal
mouse anti-histone-H3 antibody (upstate, Lake Placid, NY,
USA) as the sample loading control. The density of each
band was measured using a computer-assisted imaging
analysis system (Gene Tools Match software; Syngene,
Cambridge, UK).Statistical analysis
All data are presented as mean  standard error of the
mean (SEM). The statistical analysis was performed using
SigmaStat 3.0 software (SYSTAT Software Inc., San Jose,
CA, USA). Behavior tests were analyzed using two-way
(time and treatment) analysis of variance (ANOVA) with a
post hoc Bonferroni correction followed by subsequent one-
way ANOVA (at each time of the experiment). For immu-
noreactivity data, the intensity of each test band was
expressed as the optical density relative to that of the
average optical density for the corresponding control band.
The immunoreactivity was analyzed by one-way ANOVA,
followed by multiple comparisons with the Student-
Newman-Keuls post hoc test. A significant difference was
defined as a p value <0.05.Results
Effect of SNL on thermal hyperalgesia and tactile
allodynia
Similar to our previous report,18 SNL induced tactile
allodynia and thermal hyperalgesia on the ipsilateral
hindlimb. SNL induced a rapid and persistent reduction of
the paw withdrawal threshold to tactile and heat stimuli.
Mechanical allodynia was seen from Day 1 to Day 7 with a
maximal reduction of 40% (Fig. 1A). The paw withdrawal
threshold to radiant heat decreased significantly from Day
3 to Day 7 with a maximal reduction of 33% (Fig. 1B). By
contrast, no significant change of the withdrawal latency
was observed in either the tactile or the thermal test
between sham-operated and non-operated contralateral
hindpaw.
Figure 1 Time course changes of paw withdrawal latency to tactile and heat stimuli after spinal nerve ligation (SNL) in rats. The
paw withdrawal latency to (A) tactile and (B) radiant heat stimuli were measured in SNL rats on Day 1, 3, 5, and 7 after SNL and in
sham-operated rats (n Z 10 in each group). All data are expressed as the mean  standard error of the mean (SEM). * p < 0.05
compared with the naı¨ve controls. Con Z control.
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The time course of acetyl-H3 expression in the rat spinal
cord dorsal horn after SNL was examined by Western blot-
ting. SNL induced significant downregulation of acetyl-H3
expression on the SNL side of the spinal cord dorsal horn
(Fig. 2A); it was accompanied with HDAC1 upregulation
(Fig. 2B). There was no difference in acetyl-H3 expression
in the contralateral spinal cord dorsal horn between SNL
and sham-operated rats or between sham-operated and
naı¨ve rates (data not shown).
Intrathecal baicalin ameliorated SNL-induced
thermal hyperalgesia and tactile allodynia
On Day 7 after SNL, the maximum tactile allodynia and
thermal hyperalgesia were observed (Fig. 3A and B).Figure 2 Time course changes of acetyl-H3 and histone deacetyla
rat spinal cords. Expression of acetyl-H3 and HDAC1 in the nuclear f
operated rats and rats on Day 1, 3, 5, and 7 after SNL were examin
lane was loaded with 40 mg protein for acetyl-H3 and HDAC1 analysi
fraction. (B) Quantification of the data from (A) of five rats [mean 
sham-operated controls.Intrathecal injection of saline or morphine (15 mg) alone
provided no effect on either tactile allodynia (Fig. 3A) or
thermal hyperalgesia (Fig. 3B). By contrast, baicalin (10 mg)
significantly reversed the mechanical allodynia and thermal
hyperalgesia in SNL rats; on pretreatment with baicalin,
morphine further reversed the anti-allodynic and anti-
thermal hyperalgesic effect in comparison to the sham
control rats (Fig. 3A and B). These results demonstrate that
baicalin not only reversed the mechanical allodynia and
thermal hyperalgesia, but further restored the anti-
nociceptive effect of morphine in SNL rats.
Intrathecal baicalin administration reverses acetyl-
H3 and HDAC1 expression in SNL spinal cords
The effect of baicalin treatment on acetyl-H3 and HDAC1
expression was examined on Day 7 after SNL. Intrathecalse 1 (HDAC1) expression after spinal nerve ligation (SNL) of the
raction of the ipsilateral lumbar spinal cord dorsal horn in sham-
ed by Western blotting. (A) Representative Western blot. Each
s. Anti-histone-3 was used as the loading marker for the nuclear
standard error of the mean (SEM)]. * p < 0.05 compared to the
Figure 3 Effect of baicalin on the antinociceptive effect of morphine in spinal nerve ligated (SNL) rats. The effect of intrathecal
baicalin (10 mg) on the (A) anti-allodynic and (B) anti-thermal hyperalgesic effect of morphine (15 mg) was measured at 60 minutes
after morphine injection on Day 7 after SNL. The data are mean  standard error of the mean (SEM) (n Z 5 in each group).
* p < 0.05 compared to the sham-operated controls. ** p < 0.05 compared to the SNLþSal group. Sal Z saline; Mo Z morphine;
B Z baicalin.
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ment 30 min before morphine injection significant attenu-
ated the SNL-induced HDAC1 upregulation and reversed the
acetyl-H3 expression (Fig. 4A and B). These results show that
baicalin reversed acetyl-H3 expression in SNL rats, possibly
via the downregulation of HDAC1 expression.Discussion
In the present study, we found that (1) SNL induced a time-
dependent tactile allodynia and thermal hyperalgesia; (2)Figure 4 The expression of acetyl-H3 and histone deacetylase 1
(SNL) rats after various intrathecal treatments. On Day 7 after SNL
and HDAC1 expression were examined. (A) Representative Western
HDAC1 analysis. Anti-histone 3 was used as the loading marker for
five rats [mean  standard error of the mean (SEM)]. * p < 0.05 com
the SNLþSal groups.SNL decreased the expression of acetyl-H3 but increased
HDAC1 expression in the SNL rat spinal cords; (3) Intra-
thecal baicalin administration reversed the SNL-induced
tactile allodynia and thermal hyperalgesia; (4) baicalin
in combination with morphine administration further
enhanced morphine’s antinociceptive effect in SNL rats;
and (5) baicalin alone or pretreatment 30 minutes before
morphine injection significant attenuated the SNL-induced
HDAC1 upregulation and reversed the acetyl-H3 expression.
These results suggest that acetyl-H3 plays a key role in
neuropathic pain formation, and preventing the down-
regulation of acetyl-H3, via inhibition of HDAC1 expression,(HDAC1) in the spinal cord dorsal horn of spinal nerve ligated
, various drugs were administered intrathecally, and acetyl-H3
blot. Each lane was loaded with 40 mg protein for acetyl-H3 and
the nuclear fraction. (B) Quantification of the data from (A) of
pared to the sham-operated controls. ** p < 0.05 compared to
518 C.-H. Cherng et al.is responsible for the antihypersensitivity effect of intra-
thecal baicalin on the nociceptive responses in SNL rats.
Furthermore, it restores the antinociceptive action of
morphine.
Epigenetic alterations include covalent modifications
of chromatin and histone structure. Histones are DNA-
packaging globular proteins that undergo post-translational
modifications at specific sites of the histone N terminus
including acetylation, methylation, phosphorylation, or
ubiquitination.19 Thesemodifications alter the histoneeDNA
interaction and therefore the chromatin structure; the
consequence can be either post-transcriptional activation or
repression, depending on the type and site of the modifica-
tion. Post-translational modification of histone-H3, one of
the core histones, is important for regulation of gene tran-
scription and chromatin condensation. Histone acetylation is
catalyzed by histone acetyltransferase and removed by
HDACs.20 The mammalian genome contains at least 18 HDAC
genes that are differentially expressed in the nervous sys-
tem.21,22 However, the roles of different HDACs in pain signal
transduction in the spinal cord have not been explored.
Recent studies had reported that HDAC inhibitors prevent
the removal of acetyl groups from histones, thus amelio-
rating symptoms in many animal models of inflammatory
disease, such as arthritis,11 colitis,23 and hepatitis.24 More-
over, pharmacological intervention on the process of histone
acetylation can affect pain behavior; both systemic and
intrathecal administration of HDAC inhibitors provide an
analgesic effect in inflammatory pain models.25,26 These
results suggest that regulating the histone acetylation might
be useful in clinical pain management. In our present study,
we found that SNL not only induced mechanical allodynia
and thermal hyperalgesia, but also induced epigenetic
modifications (acetyl-H3 downregulation and HDAC1
overexpression). These results indicate that epigenetic
mechanisms could be involved in the development and
maintenance of chronic neuropathic pain conditions.
According to the present study, we suggest that SNLmay turn
on some inflammatory genes and turn off some anti-
inflammatory genes, thereby inducing epigenetic modifica-
tions, which facilitate neuropathic pain formation. Recent
literature reviews further indicate the importance of in-
flammatory mediators in the establishment of epigenetic
modifications.5 Epigenetic techniques such as RNA interfer-
ence have been employed in pain research to show the
contribution of certain proteins to nociception. Moreover,
studies suggested that transcriptional regulation might be a
novel treatment for chronic neuropathic pain.27,28 There-
fore, the use of epigenetic manipulation techniques, such as
administration of HDAC inhibitors, to inhibit transcription of
known nociceptive proteins may improve the neuropathic
pain management in the clinical setting, particularly
enhancing the analgesic effect of opioids; not surprisingly, it
was shown that HDAC inhibitors regulated opioid receptor
expression.29,30 Furthermore, the analgesic effect of HDAC
inhibitors was demonstrated to increase metabotropic
glutamate 2 receptor expression in dorsal root ganglia neu-
rons in formalin-induced inflammatory pain animals.31 In our
present study, we found that intrathecal baicalin inhibits
HDAC1 expression and reverses SNL-induced acetyl-H3
downregulation. According to this result, we suggest that
baicalin may regulate the epigenetic alterations, andreverse the SNL-induced histone-3 modification. However,
this study has some limitations, we only focused on the
histone-H3 acetylation; the changes of histone methylation
should also be further investigated to complete the whole
histone modification during neuropathic pain development
and their role in morphine tolerance formation.
As we know, morphine is less effective in treating
neuropathic pain. A combination of mechanistically distinct
analgesics will provide either an additive or synergistic ef-
fect to improve the efficacy of morphine at lower doses with
fewer side effects thanwith the use of a single agent or a high
dose of morphine.15,18,32 Evidence indicates that activating
of neuroinflammatory cascade is a major mechanism of
neuropathic pain,33e36 and co-administration of drugs with
inhibitory effect on neuroinflammation may improve clinical
neuropathic pain management.18,37,38 Our previous stud-
ies13e15,38,39 demonstrated that ultra-low dose ()-naloxone
provides an anti-inflammatory effect, which restores the
rat’s normal physiology (attenuation of the excitatory amino
acid concentration in cerebrospinal fluid (CSF), inhibition of
neuroinflammation, reversion of the nociceptive effect to
baseline, and restoration of m-opioid receptor/Gi-protein
coupling) in pertussis toxin (PTX)-induced neuropathic pain
rats to that seen in naı¨ve rats, thus recovering the anti-
nociceptive effect of morphine. These results suggest that
inhibition of neuroinflammation is a valuable target in pain
management. It has been reported that baicalin provided an
anti-inflammatory effect and improved the analgesic effect
in carrageenan-evoked thermal hyperalgesic rats.40 These
effects are associated with inhibition of inflammatory
mediator release, including PGE2, nitric oxide, and proin-
flammatory cytokines, accompanied by an increase in IL-10
expression. Moreover, Li et al indicate that baicalin could
inhibit the inflammatory reaction in injured neurons via
downregulation of Toll-like receptor 2/4 (TLR2/4) and TNF-a
expression in both mRNA and protein in cerebral ischemia-
reperfusion mice.41 Our present study cannot differentiate
the interaction between baicalin and HDAC1, however, our
preliminary result found that intrathecal baicalin signifi-
cantly inhibited HDAC1 phosphorylation in SNL rat spinal
cords; it suggests that baicalin might directly affect the
HDAC1 protein structure by modification at the post-
translational level. Taken together, we suggest that baica-
lin ameliorates hyperalgesia and reverses the anti-
nociceptive effect of morphine by reversing global histone-
H3 acetylation and suppressing HDAC1 expression, but also
inhibiting neuroinflammation. We therefore believe that
baicalin has potential as an analgesic adjuvant in clinical
pain management.
In summary, our results suggest that histone-H3 acety-
lation may play a role in neuropathic pain formation. Inhi-
bition of HDACs with drugs such as baicalin might be a new
therapeutic approach for neuropathic pain management
and provide some hints for further studies on the role of
histone modification in neuropathic pain.Acknowledgments
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